Skip to main content
Equibles

STATE STREET CORP

Position in VERU — Veru Inc.

CIK 93751 BOSTON, MA
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$172,162
+$50,604 QoQ
Shares Held
55,004
0.0% QoQ
Ownership
0.323%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. VERU ranks #346 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in VERU

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $172,162 55,004
2026-03-31 $121,558 55,004
2025-12-31 $117,708 55,004
2025-09-30 $209,015 55,004
2025-06-30 $319,040 550,069
2025-03-31 $1,094,678 2,234,038
2024-12-31 $1,481,370 2,279,031
2024-09-30 $1,595,490 2,072,065
2024-06-30 $1,669,568 1,987,582
2024-03-31 $151,942 217,061
2023-12-31 $156,283 217,061
2023-09-30 $156,283 217,061
2023-06-30 $258,302 217,061
2023-03-31 $1,400,473 1,207,305
2022-12-31 $6,417,781 1,215,489
2022-09-30 $14,361,857 1,246,689
2022-06-30 $13,767,400 1,218,354
2022-03-31 $5,621,762 1,163,926
2021-12-31 $6,378,563 1,082,948
2021-09-30 $9,225,126 1,081,492
2021-06-30 $8,414,524 1,042,692
2021-03-31 $9,400,968 872,075
2020-12-31 $7,356,081 850,414
2020-09-30 $1,451,417 553,976
2020-06-30 $1,777,461 532,174
2020-03-31 $41,555 12,708